TelyRx Holdings Inc. is seeing a significant drop in its stock price, which reflects investor worries in a tough market.
In the latest trading session, TelyRx Holdings Inc. (TELY.TO) fell by 3.33%, closing at CA$2.90. This decline raises concerns about the company's market position and future outlook, especially considering its recent performance metrics.
Investor takeaway: Investors should be cautious, as TelyRx's stock has shown weakness in today’s market, and the lack of major news might signal deeper issues.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$77.08M
52W high
$4.25
52W low
$2.00
1W change
+20.83%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 106.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+106.9% Upside
Current Price
C$2.90
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.8%
Annualized
90-Day Vol
99.7%
Annualized
Trend (90d)
-14.2%
Annualized drift
90d Mean
C$2.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.85 | C$2.00 – C$4.06 |
| 60 trading days | C$2.80 | C$1.70 – C$4.63 |
| 90 trading days | C$2.76 | C$1.49 – C$5.09 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
TelyRx Holdings Inc. Market Cap: CA$77.08 Million
With a market cap of CA$77.08 million and a share price of CA$2.90, TelyRx's financial health is under scrutiny as it navigates a challenging trading environment.
Bull case
Despite the recent downturn, TelyRx has demonstrated growth potential by recently surpassing one million prescriptions filled. This milestone could be a positive sign for future revenue.
Bear case
The stock's drop today might reflect broader market skepticism about TelyRx's ability to maintain its growth, particularly given its negative profit margin.
Market Performance Overview
TelyRx Holdings Inc. had a tough trading day, with its stock price falling by 3.33%. This decline is concerning, especially since the company has seen growth in prescription volume that hasn't yet built investor confidence.
Investor Sentiment
The absence of recent news about TelyRx may have played a role in today’s decline. Investors are likely weighing the company's financial performance, including its negative profit margin, against its growth potential. As TelyRx faces these challenges, keeping investor confidence will be crucial.
Looking Ahead
As TelyRx continues to expand its digital pharmacy services, stakeholders will be closely watching how the company addresses its current weaknesses. Future announcements about financial results or strategic initiatives could be key to reversing today’s negative sentiment.
Advertisement
